THE SINGLE BEST STRATEGY TO USE FOR SEMAGLUTIDE WEEK 1-12 BUNDLE

The trial achieved both of those its Major endpoints, with semaglutide 2.4 mg demonstrating statistically major and superior advancements in liver fibrosis without any worsening of steatohepatitis, along with resolution of steatohepatitis without having worsening of liver fibrosis in those with MASH when compared to placebo.1Continue to keep all ap